Molecular Docking Assessment of Efficacy of Different Clinically Used Arsenic Chelator Drugs

Table 1

Organs affected by arsenic and the most abundant protein(s) in that organ.

Affected organ by arsenic	Abundant protein of the organ
Skin [18]	Collagen
Heart muscle [19]	Lactate dehydrogenase (LDH)
Reproduction, carcinogenicity [20]	Estrogen receptor alpha (ER-α)
Liver [21]	Thioredoxin reductase (TDR)
Liver [22]	Glutathione reductase (GTH)
Energy metabolism in all cells [23]	Pyruvate dehydrogenase (PDH)
Cytoskeletal structure [24]	Tubulin
Cytoskeletal structure [25]	Actin
Blood (serum) [16, 26]	Albumin
Liver, kidney and brain [17, 21, 26]	Spermine and spermidine